Unity Biotechnology shareholders approve dissolution plan at special meeting on Sept 18, 2025

Unity Biotechnology, Inc.

Stockholders approved the liquidation and dissolution of the company with 450,228,768 votes for, 150,685,568 against.
The Board retains sole discretion to proceed with dissolution, including timing of filing Certificate of Dissolution.
Board may abandon or modify the dissolution plan if deemed not in best interest of stockholders.
Special meeting quorum achieved with 97.36% of outstanding voting power represented.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.